International Personalized Medicine Conference Held In EduCity@Iskandar | Asian Scientist Magazine | Science, Technology and Medicine News U...

International Personalized Medicine Conference Held In EduCity

Companion animals: Translational scientist’s new best friends | Science Translational Medicine

Companion animals: Translational scientist’s new best friends

A group of researchers at Stanford and elsewhere is retracting a 2013 paper that another scientist told Nature was “one of the biggest things to happen in the narcolepsy field for some time.” The Science Translational Medicine paper caused a buzz because it claimed to show that narcolepsy was an autoimmune disease. Here’s the notice: A.K. …

Authors retract paper “confirming” that narcolepsy is an autoimmune disease - Retraction Watch

Theme "To Frame An Admiring Portal For Pioneering Cancer Therapy and Cell Signaling Findings", conference will explore the advances in Medical Approaches, Oncology, Translational Oncology, Computational Technologies.  #medical #conference #scientist #researchers #business  #cell #cancer #therapy.

Theme "To Frame An Admiring Portal For Pioneering Cancer Therapy and Cell Signaling Findings", conference will explore the advances in Medical Approaches, Oncology, Translational Oncology, Computational Technologies. #medical #conference #scientist #researchers #business #cell #cancer #therapy.

Jan 2016 The Translational Scientist article: "Animal Alternatives Could the lab rat be heading for retirement? A new breed of in vitro tissues and organs are being engineered to replace animal models – and the developers aim to make them accessible to all."

Could the lab rat be heading for retirement? We explore a new breed of in vitro models.

Jan 2016 The Translational Scientist article: "Untangling Tau As a neurologist, Bradley Hyman has seen first-hand the impact of Alzheimer’s disease on patients and their families. His lab examines the genetic and neuropathophysiological factors that play a part in the disease, and recently discovered a rare pathological form of the tau protein, which may hold the key to how Alzheimer’s spreads through the brain."

As a neurologist, Bradley Hyman has seen first-hand the impact of Alzheimer’s disease on patients and their families.

Dr Troy McSherry, Principal Scientist, Biologics Process Design R&D, Abbott Diagnostics Division, speaks on 'A comprehensive analytical approach used to describe an unexpected antibody post-translational modification' - Track 4 #Bioproduction13

Dr Troy McSherry, Principal Scientist, Biologics Process Design R&D, Abbott Diagnostics Division, speaks on 'A comprehensive analytical approach used to describe an unexpected antibody post-translational modification' - Track 4

Jan 2016 The Translational Scientist article: "From Astrophysics to Astrocytes A galaxy-mapping statistical model suggests that star-shaped astrocytes are repelled by Alzheimer’s plaques."

Jan 2016 The Translational Scientist article: "From Astrophysics to Astrocytes A galaxy-mapping statistical model suggests that star-shaped astrocytes are repelled by Alzheimer’s plaques.

Jan 2016 The Translational Scientist article: "The Overactive Brain Michela Gallagher was studying aging in lab rats when an unusual finding launched her on a translational journey that now sees her poised to initiate a Phase III trial of a drug to delay the onset of Alzheimer’s dementia."

Can a drug to dampen an overactive hippocampus help delay the onset of dementia?

Opinion - Translational Research in Crisis on The Scientist

Opinion: Reasons for the R&D Crisis

Pinterest
Search